Gipfel Life Sciences specializes in biotechnology. We focus on personalized medicine and recombinant antibody development. We use NGS and organoid models to provide personalized treatment options based on genetic and molecular patterns of individuals.
company data |
|
| employees: | <= 5 |
| legal form: | Gesellschaft mit beschränkter Haftung |
| founding date: | 2023 |
| Mitglied im Cluster: | |
export countries: |
|
| Austria, Germany and other European Member Countries, Switzerland, U.K., Japan, China, USA | |
references: |
|
| ETH FGCZ, Oxford University, AIST Japan, Austrian Drug Screening Institute, Precision System Science Japan | |
products and services: |
|
| Precision medicine, Phytoengineering, recombinant antibody development, Kampo medicine production & registration, Computational Drug Development. | |
research and innovation |
|
| Metabolomics to assess the tears of GBM patients for disease stratification / In-vivo Drug Phenotyping / Artificial vein development to prevent metastasis | |
contact information |
|
| street: | Bahnhof Umgebung, 4 |
| ZIP code: | 6170 |
| city: | Zirl |
| country: | Österreich |
| phone: | +43 664 5005 920 |
| email: | ozan@gipfellifesciences.com |
| website: | https://www.gipfellifesciences.com |
|
contact: |
PhD Ozan Fidan |
| function: | |
| phone: | +43 664 5005 920 |
| email: | ozan@gipfellifesciences.com |
|
contact: |
Mag. Gökhan Senli |
| function: | |
| phone: | +43 664 438 8146 |
| email: | g.senli@gipfellifesciences.com |
-
competences and specialization
- biotechnology
- Disease Phenotyping
- NGS
- Phytoengineering
- Precision Medicine
- Recombinant Antibodies